Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: ANI Pharmaceuticals Inc., 3 years.
ANI Pharmaceuticals Inc.
Director
Cardiff Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | ANI Pharmaceuticals Inc. | Grant or award | +4,357 | — | — |
| Dec 5, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −1,800 | $81.15 | $146,070 |
| May 22, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +4,336 | — | — |
| Dec 12, 2024 | Cardiff Oncology Inc. | Open-market purchase | +10,000 | $3.42 | $34,200 |
| May 21, 2024 | ANI Pharmaceuticals Inc. | Grant or award | +4,410 | — | — |
| May 16, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −2,000 | $63.87 | $127,740 |
| May 23, 2023 | ANI Pharmaceuticals Inc. | Grant or award | +6,865 | — | — |
Questions about Renee P. Tannenbaum
What boards is Renee P. Tannenbaum on?
Renee P. Tannenbaum sits on the boards of ANI Pharmaceuticals Inc. and Cardiff Oncology Inc.
How long has Renee P. Tannenbaum served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.